ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prediction of Prognosis and Immunotherapy Response with a Novel Natural Killer Cell Marker Genes Signature in Osteosarcoma

Li, Qinwen; Huang, Xiaoyan; Zhao, Youfang*1
Cancer Biotherapy and Radiopharmaceuticals2023-10-27DOI: 10.1089/cbr.2023.0103
6阅读
引用收藏
分享

摘要

Background: Natural killer (NK) cells are characterized by their antitumor efficacy without previous sensitization, which have attracted attention in tumor immunotherapy. The heterogeneity of osteosarcoma (OS) has hindered therapeutic application of NK cell-based immunotherapy. The authors aimed to construct a novel NK cell-based signature to identify certain OS patients more responsive to immunotherapy.Materials and Methods: A total of eight publicly available datasets derived from patients with OS were enrolled in this study. Single-cell RNA sequencing data obtained from the Gene Expression Omnibus (GEO) database were analyzed to screen NK cell marker genes. Least Absolute Shrinkage and Selection Operator (LASSO) Cox regression analysis was used to construct an NK cell-based prognostic signature in the TARGET-OS dataset. The differences in immune cell infiltration, immune system-related metagenes, and immunotherapy response were evaluated among risk subgroups. Furthermore, this prognostic signature was experimentally validated by reverse transcription-quantitative real-time PCR (RT-qPCR).Results: With differentially expressed NK cell marker genes screened out, a five-gene NK cell-based prognostic signature was constructed. The prognostic predictive accuracy of the signature was validated through internal clinical subgroups and external GEO datasets. Low-risk OS patients contained higher abundances of infiltrated immune cells, especially CD8 T cells and naive CD4 T cells, indicating that T cell exhaustion states were present in the high-risk OS patients. As indicated from correlation analysis, immune system-related metagenes displayed a negative correlation with risk scores, suggesting the existence of immunosuppressive microenvironment in OS. In addition, based on responses to immune checkpoint inhibitor therapy in two immunotherapy datasets, the signature helped predict the response of OS patients to anti-programmed cell death protein 1 (PD-1) or anti-programmed cell death ligand 1 (PD-L1) therapy. RT-qPCR results demonstrated the roughly consistent relationship of these five gene expressions with predicting outcomes.Conclusions: The NK cell-based signature is likely to be available for the survival prediction and the evaluation of immunotherapy response of OS patients, which may shed light on subsequent immunotherapy choices for OS patients. In addition, the authors revealed a potential link between immunosuppressive microenvironment and OS.

学科与关键词

关键词
scRNA-seqNK cell marker genes signatureosteosarcomaprognosisimmunotherapy response
相关
加载中…
  • Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma
    Yang, Bingsheng; Su, Zexin; Chen, Guoli; Zeng, Zhirui; Tan, Jianye; Wu, Guofeng; Zhu, Shuang*; Lin, Lijun*Oncology Letters, 2021, 21(3): 180.被引 20
  • Probing the Potential of Defense Response-Associated Genes for Predicting the Progression, Prognosis, and Immune Microenvironment of Osteosarcoma
    Huang, Liangkun; Sun, Fei; Liu, Zilin; Jin, Wenyi; Zhang, Yubiao; Chen, Junwen; Zhong, Changheng; Liang, Wanting; Peng, Hao*Cancers, 2023, 15(8): 2405.被引 6
  • Screening and verification of prognostic lncRNA markers related to immune infiltration in the metastasis of osteosarcoma
    He, Chuan; Wang, Xiaolong; Ni, Linying; Song, Chunyu; Mai, Wei*Translational Cancer Research, 2022, 11(9): 3235-3249.
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Biotherapy and Radiopharmaceuticals
发表日期
2023-10-27
DOI
10.1089/cbr.2023.0103
语言
ENGLISH
成果收录
SCIE

作者

  • L

    Li, Qinwen (第一作者)

    1 · china three gorges univ

  • H

    Huang, Xiaoyan

    china three gorges univ

查看全部 3 位作者收起作者
  • Z

    Zhao, Youfang (通讯)

    china three gorges univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417